References
Key articles
Görög A, Antiga E, Caproni M, et al. S2k guidelines (consensus statement) for diagnosis and therapy of dermatitis herpetiformis initiated by the European Academy of Dermatology and Venereology (EADV). J Eur Acad Dermatol Venereol. 2021 Jun;35(6):1251-77.Full text Abstract
Caproni M, Antiga E, Melani L, et al. Guidelines for the diagnosis and treatment of dermatitis herpetiformis. J Eur Acad Dermatol Venereol. 2009 Jun;23(6):633-8.Full text Abstract
Hill ID, Fasano A, Guandalini S, et al. NASPGHAN clinical report on the diagnosis and treatment of gluten-related disorders. J Pediatr Gastroenterol Nutr. 2016 Jul;63(1):156-65. Abstract
Al-Toma A, Volta U, Auricchio R, et al. European Society for the Study of Coeliac Disease (ESsCD) guideline for coeliac disease and other gluten-related disorders. United European Gastroenterol J. 2019 Jun;7(5):583-613.Full text Abstract
Reference articles
1. Antiga E, Maglie R, Quintarelli L, et al. Dermatitis herpetiformis: novel perspectives. Front Immunol. 2019 Jun 11:10:1290.Full text Abstract
2. Görög A, Antiga E, Caproni M, et al. S2k guidelines (consensus statement) for diagnosis and therapy of dermatitis herpetiformis initiated by the European Academy of Dermatology and Venereology (EADV). J Eur Acad Dermatol Venereol. 2021 Jun;35(6):1251-77.Full text Abstract
3. Ludvigsson JF, Bai JC, Biagi F, et al. Diagnosis and management of adult coeliac disease: guidelines from the British Society of Gastroenterology. Gut. 2014 Aug;63(8):1210-28.Full text Abstract
4. Antiga E, Verdelli A, Calabrò A, et al. Clinical and immunopathological features of 159 patients with dermatitis herpetiformis: an Italian experience. G Ital Dermatol Venereol. 2013 Apr;148(2):163-9. Abstract
5. Salmi TT, Hervonen K, Kautiainen H, et al. Prevalence and incidence of dermatitis herpetiformis: a 40-year prospective study from Finland. Br J Dermatol. 2011 Aug;165(2):354-9. Abstract
6. West J, Fleming KM, Tata LJ, et al. Incidence and prevalence of celiac disease and dermatitis herpetiformis in the UK over two decades: population-based study. Am J Gastroenterol. 2014 May;109(5):757-68.Full text Abstract
7. Antiga E, Bonciolini V, Cazzaniga S, et al. Female patients with dermatitis herpetiformis show a reduced diagnostic delay and have higher sensitivity rates at autoantibody testing for celiac disease. Biomed Res Int. 2019 Dec 29:2019:6307035.Full text Abstract
8. Bolotin D, Petronic-Rosic V. Dermatitis herpetiformis. Part I. Epidemiology, pathogenesis, and clinical presentation. J Am Acad Dermatol. 2011 Jun;64(6):1017-24; quiz 1025-6. Abstract
9. Ohata C, Ishii N, Niizeki H, et al. Unique characteristics in Japanese dermatitis herpetiformis. Br J Dermatol. 2016 Jan;174(1):180-3. Abstract
10. Zone JJ. Skin manifestations of celiac disease. Gastroenterology. 2005 Apr;128(4 suppl 1):S87-91.Full text Abstract
11. Caproni M, Antiga E, Melani L, et al. Guidelines for the diagnosis and treatment of dermatitis herpetiformis. J Eur Acad Dermatol Venereol. 2009 Jun;23(6):633-8.Full text Abstract
12. Nisticò L, Fagnani C, Coto I, et al. Concordance, disease progression, and heritability of coeliac disease in Italian twins. Gut. 2006 Jun;55(6):803-8.Full text Abstract
13. Hietikko M, Hervonen K, Ilus T, et al. Ex vivo culture of duodenal biopsies from patients with dermatitis herpetiformis indicates that transglutaminase 3 antibody production occurs in the gut. Acta Derm Venereol. 2018 Mar 13;98(3):366-72. Abstract
14. Makino T, Yoshihisa Y, Mizawa M, et al. Increased serum levels of Th2-type cytokines and eotaxin in fibrillar-type dermatitis herpetiformis. Acta Derm Venereol. 2017 May 8;97(5):642-3. Abstract
15. Mansikka E, Hervonen K, Kaukinen K, et al. Prognosis of dermatitis herpetiformis patients with and without villous atrophy at diagnosis. Nutrients. 2018 May 19;10(5):641.Full text Abstract
16. Hill ID, Fasano A, Guandalini S, et al. NASPGHAN clinical report on the diagnosis and treatment of gluten-related disorders. J Pediatr Gastroenterol Nutr. 2016 Jul;63(1):156-65. Abstract
17. Antiga E, Caproni M. The diagnosis and treatment of dermatitis herpetiformis. Clin Cosmet Investig Dermatol. 2015 May 13:8:257-65.Full text Abstract
18. Lähteenoja H, Irjala K, Viander M, et al. Oral mucosa is frequently affected in patients with dermatitis herpetiformis. Arch Dermatol. 1998 Jun;134(6):756-8. Abstract
19. Bonciolini V, Bonciani D, Verdelli A, et al. Newly described clinical and immunopathological feature of dermatitis herpetiformis. Clin Dev Immunol. 2012;2012:967974.Full text Abstract
20. Vale ECSD, Dimatos OC, Porro AM, et al. Consensus on the treatment of autoimmune bullous dermatoses: dermatitis herpetiformis and linear IgA bullous dermatosis - Brazilian Society of Dermatology. An Bras Dermatol. 2019 Apr;94(2 suppl 1):48-55.Full text Abstract
21. Al-Toma A, Volta U, Auricchio R, et al. European Society for the Study of Coeliac Disease (ESsCD) guideline for coeliac disease and other gluten-related disorders. United European Gastroenterol J. 2019 Jun;7(5):583-613.Full text Abstract
22. Zone JJ, Meyer LJ, Petersen MJ. Deposition of granular IgA relative to clinical lesions in dermatitis herpetiformis. Arch Dermatol. 1996 Aug;132(8):912-8. Abstract
23. Beutner EH, Baughman RD, Austin BM, et al. A case of dermatitis herpetiformis with IgA endomysial antibodies but negative direct immunofluorescent findings. J Am Acad Dermatol. 2000 Aug;43(2 pt 2):329-32. Abstract
24. Warren SJ, Cockerell CJ. Characterization of a subgroup of patients with dermatitis herpetiformis with nonclassical histologic features. Am J Dermatopathol. 2002 Aug;24(4):305-8. Abstract
25. Dahlbom I, Korponay-Szabó IR, Kovács JB, et al. Prediction of clinical and mucosal severity of coeliac disease and dermatitis herpetiformis by quantification of IgA/IgG serum antibodies to tissue transglutaminase. J Pediatr Gastroenterol Nutr. 2010 Feb;50(2):140-6. Abstract
26. Norsa L, Shamir R, Zevit N, et al. Cardiovascular disease risk factor profiles in children with celiac disease on gluten-free diets. World J Gastroenterol. 2013 Sep 14;19(34):5658-64.Full text Abstract
27. Kumar V, Jarzabek-Chorzelska M, Sulej J, et al. Tissue transglutaminase and endomysial antibodies-diagnostic markers of gluten-sensitive enteropathy in dermatitis herpetiformis. Clin Immunol. 2001 Mar;98(3):378-82. Abstract
28. Volta U, Molinaro N, De Franchis R, et al. Correlation between IgA antiendomysial antibodies and subtotal villous atrophy in dermatitis herpetiformis. J Clin Gastroenterol. 1992 Jun;14(4):298-301. Abstract
29. Reunala T, Collin P. Diseases associated with dermatitis herpetiformis. Br J Dermatol. 1997 Mar;136(3):315-8. Abstract
30. Bonciolini V, Antiga E, Bianchi B, et al. Granular IgA deposits in the skin of patients with coeliac disease: is it always dermatitis herpetiformis? Acta Derm Venereol. 2019 Jan 1;99(1):78-83. Abstract
31. Ständer S. Atopic Dermatitis. N Engl J Med. 2021 Mar 25;384(12):1136-43. Abstract
32. Chosidow O. Clinical practices. Scabies. N Engl J Med. 2006 Apr 20;354(16):1718-27. Abstract
33. Paller AS, Mancini J. Hurwitz clinical pediatric dermatology: a textbook of skin disorders of childhood and adolescence. 5th ed. Philadelphia, PA: Elsevier Saunders; 2016.
34. Misery L. Chronic prurigo. Br J Dermatol. 2022 Oct;187(4):464-71. Abstract
35. Antiga E, Caproni M, Fabbri P. Linear immunoglobulin a bullous dermatosis: need for an agreement on diagnostic criteria. Dermatology. 2013;226(4):329-32.Full text Abstract
36. Korman NJ. Bullous pemphigoid. The latest in diagnosis, prognosis, and therapy. Arch Dermatol. 1998 Sep;134(9):1137-41. Abstract
37. Bakker CV, Terra JB, Pas HH, et al. Bullous pemphigoid as pruritus in the elderly: a common presentation. JAMA Dermatol. 2013 Aug;149(8):950-3.Full text Abstract
38. Borradori L, Van Beek N, Feliciani C, et al. Updated S2 K guidelines for the management of bullous pemphigoid initiated by the European Academy of Dermatology and Venereology (EADV). J Eur Acad Dermatol Venereol. 2022 Oct;36(10):1689-704.Full text Abstract
39. Hayder F, Bahloul E, Sellami K, et al. Pemphigus herpetiformis in a 4-year-old child: case report and review of the literature. Clin Case Rep. 2022 Mar;10(3):e05567.Full text Abstract
40. Zingone F, Maimaris S, Auricchio R, et al. Guidelines of the Italian societies of gastroenterology on the diagnosis and management of coeliac disease and dermatitis herpetiformis. Dig Liver Dis. 2022 Oct;54(10):1304-19. Abstract
41. Alonso-Llamazares J, Gibson LE, Rogers RS 3rd. Clinical, pathologic, and immunopathologic features of dermatitis herpetiformis: review of the Mayo Clinic experience. Int J Dermatol. 2007 Sep;46(9):910-9. Abstract
42. Varpuluoma O, Jokelainen J, Försti AK, et al. Dermatitis herpetiformis and celiac disease increase the risk of bullous pemphigoid. J Invest Dermatol. 2019 Mar;139(3):600-4.Full text Abstract
43. Lewis HM, Renaula TL, Garioch JJ, et al. Protective effect of gluten-free diet against development of lymphoma in dermatitis herpetiformis. Br J Dermatol. 1996 Sep;135(3):363-7. Abstract
44. Collin P, Salmi TT, Hervonen K, et al. Dermatitis herpetiformis: a cutaneous manifestation of coeliac disease. Ann Med. 2017 Feb;49(1):23-31.Full text Abstract
45. Mehtab W, Singh N, Malhotra A, et al. All that a physician should know about gluten-free diet. Indian J Gastroenterol. 2018 Sep;37(5):392-401. Abstract
46. Bledsoe AC, King KS, Larson JJ, et al. Micronutrient deficiencies are common in contemporary celiac disease despite lack of overt malabsorption symptoms. Mayo Clin Proc. 2019 Jul;94(7):1253-60. Abstract
47. Vici G, Belli L, Biondi M, et al. Gluten free diet and nutrient deficiencies: a review. Clin Nutr. 2016 Dec;35(6):1236-41. Abstract
48. Bascuñán KA, Vespa MC, Araya M. Celiac disease: understanding the gluten-free diet. Eur J Nutr. 2017 Mar;56(2):449-59. Abstract
49. Haffenden GP, Blenkinsopp WK, Ring NP, et al. The potassium iodide patch test in the dermatitis herpetiformis in relation to treatment with a gluten-free diet and dapsone. Br J Dermatol. 1980 Sep;103(3):313-7. Abstract
50. Paek SY, Steinberg SM, Katz SI. Remission in dermatitis herpetiformis: a cohort study. Arch Dermatol. 2011 Mar;147(3):301-5.Full text Abstract
51. Hietikko M, Hervonen K, Salmi T, et al. Disappearance of epidermal transglutaminase and IgA deposits from the papillary dermis of patients with dermatitis herpetiformis after a long-term gluten-free diet. Br J Dermatol. 2018 Mar;178(3):e198-e201. Abstract
52. Pasternack C, Hervonen K, Mansikka E, et al. Persistent skin symptoms after diagnosis and on a long-term gluten-free giet in dermatitis herpetiformis. Acta Derm Venereol. 2021 Sep 22;101(9):adv00555.Full text Abstract
53. Pasternack C, Hervonen K, Mansikka E, et al. Sex-differences in gluten-free dietary adherence and clinical symptoms in patients with long-term treated dermatitis herpetiformis. Acta Derm Venereol. 2022 May 16;102:adv00713.Full text Abstract
54. Guennouni M, Admou B, El Khoudri N, et al. Gluten contamination in labelled gluten-free, naturally gluten-free and meals in food services in low-, middle- and high-income countries: a systematic review and meta-analysis. Br J Nutr. 2022 May 28;127(10):1528-42.Full text Abstract
55. Bolotin D, Petronic-Rosic V. Dermatitis herpetiformis. Part II. Diagnosis, management, and prognosis. J Am Acad Dermatol. 2011 Jun;64(6):1027-33; quiz 1033-4. Abstract
56. Zhu YI, Stiller MJ. Dapsone and sulfones in dermatology: overview and update. J Am Acad Dermatol. 2001 Sep;45(3):420-34. Abstract
57. Coleman MD. Dapsone-mediated agranulocytosis: risks, possible mechanisms and prevention. Toxicology. 2001 Apr 12;162(1):53-60. Abstract
58. Willsteed E, Lee M, Wong LC, et al. Sulfasalazine and dermatitis herpetiformis. Australas J Dermatol. 2005 May;46(2):101-3. Abstract
59. Shah SA, Ormerod AD. Dermatitis herpetiformis effectively treated with heparin, tetracycline and nicotinamide. Clin Exp Dermatol. 2000 May;25(3):204-5. Abstract
60. Zemtsov A, Neldner KH. Successful treatment of dermatitis herpetiformis with tetracycline and nicotinamide in a patient unable to tolerate dapsone. J Am Acad Dermatol. 1993 Mar;28(3):505-6. Abstract
61. Wang Y, Yang B, Zhou G, et al. Two cases of dermatitis herpetiformis successfully treated with tetracycline and niacinamide. Acta Dermatovenerol Croat. 2018 Oct;26(3):273-5. Abstract
62. Rai S, Kaur A, Chopra CS. Gluten-free products for celiac susceptible people. Front Nutr. 2018 Dec 17:5:116.Full text Abstract
63. Mansikka E, Hervonen K, Kaukinen K, et al. Gluten challenge induces skin andsmall bowel relapse in long-term gluten-free diet-treated dermatitis herpetiformis. J Invest Dermatol. 2019 Oct;139(10):2108-14.Full text Abstract
64. Antiga E, Caproni M, Pierini I, et al. Gluten-free diet in patients with dermatitis herpetiformis: not only a matter of skin. Arch Dermatol. 2011 Aug;147(8):988-9. Abstract
65. Hervonen K, Alakoski A, Salmi TT, et al. Reduced mortality in dermatitis herpetiformis: a population-based study of 476 patients. Br J Dermatol. 2012 Dec;167(6):1331-7. Abstract
66. Viljamaa M, Kaukinen K, Pukkala E, et al. Malignancies and mortality in patients with coeliac disease and dermatitis herpetiformis: 30-year population-based study. Dig Liver Dis. 2006 Jun;38(6):374-80. Abstract
Use of this content is subject to our disclaimer